Disease | peripartum cardiomyopathy |
Comorbidity | C0878544|cardiomyopathy |
Sentences | 4 |
PubMedID- 22412221 | The prevalence of mutations associated with familial dilated-cardiomyopathy genes in patients with peripartum cardiomyopathy suggests an overlap in the clinical spectrum of these 2 diseases.treatment for peripartum cardiomyopathy includes conventional pharmacologic heart-failure therapies-principally diuretics, angiotensin-converting enzyme inhibitors, vasodilators, digoxin, beta-blockers, anticoagulants, and peripartum cardiomyopathy-targeted therapies. |
PubMedID- 22588321 | Aims: persistence of left ventricular (lv) systolic dysfunction after 6 months of diagnosis is believed to be a marker of an irreversible cardiomyopathy in peripartum cardiomyopathy (ppcm). |
PubMedID- 20027040 | Conclusion: although only a minority of hospitalizations for cardiomyopathy are consistent with peripartum cardiomyopathy, cardiomyopathy and other myocardial disorders are important contributors to severe obstetric complications. |
PubMedID- 21406100 | This figure shows significant increases in heart failure causes associated strongly with pregnancy, including iron deficiency anemia and cardiomyopathy, a target inclusive of peripartum cardiomyopathy. |
Page: 1